Biocon Biologics, Sandoz Australia ink pact for biosimilars Trastuzumab, Bevacizumab Ruchika Sharma9 Feb 2024 12:30 PM ISTTrastuzumab is a biosimilar of Herceptin and Bevacizumab is a biosimilar of Avastin - both biosimilars are available on the PBS and utilised for the...
Sandoz to buy eye drug Cimerli business from Coherus BioSciences for over Rs 1413 crore Ruchika Sharma24 Jan 2024 1:30 PM ISTBasel: Sandoz has signed an agreement to acquire the US biosimilar ranibizumab CIMERLI (ranibizumab-eqrn) from Coherus BioSciences, Inc. for an...
CVS Health to remove AbbVie rheumatoid arthritis drug Humira from some drug reimbursement lists in April Ruchika Sharma4 Jan 2024 12:30 PM ISTA CVS spokesperson said the company expects most of its customers to transition their coverage to biosimilars of Humira, known chemically as...
Biocon Biologics, Sandoz ink pact for distribution of immune disorder injection Adalimumab in Japan Ruchika Sharma23 Dec 2023 12:30 PM ISTAdalimumab BS for subcutaneous injection [FKB] is a biosimilar of Humira (generic name: adalimumab (genetical recombination)) and is indicated for...
Aspen Pharmacare to buy Chinese business of Sandoz for USD 100.6 million Ruchika Sharma5 Dec 2023 4:50 PM ISTAdditionally, Aspen will dispose of the commercialisation rights and related intellectual property for four anaesthetic products currently sold by...
Sandoz opens two new European facilities Ruchika Sharma15 Nov 2023 10:00 AM ISTBasel: Sandoz has opened two new European facilities, in line with its ongoing plans to strengthen sustainable development and supply of critical...
Novartis concludes Sandoz spin-off Ruchika Sharma5 Oct 2023 10:30 AM ISTBasel: Novartis has completed the Spin-off of Sandoz, its Generics and Biosimilars business, through a dividend-in-kind distribution to holders of...
Sandoz bags European Commission approval for biosimilar Tyruko for multiple sclerosis Ruchika Sharma26 Sept 2023 12:30 PM ISTBasel: Sandoz has announced that the European Commission (EC) has granted marketing authorization for the first and only biosimilar Tyruko...
Sandoz gets EMA Committee positive opinion for breast, gastric cancer biosimilar trastuzumab Ruchika Sharma19 Sept 2023 12:30 PM ISTBasel: Sandoz has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), has adopted a...
Novartis shareholders approve proposed 100 percent Spinoff of Sandoz Ruchika Sharma16 Sept 2023 3:30 PM ISTBasel: Novartis shareholders approved the proposed 100% Spin-off of Sandoz, the Generics and Biosimilars business of Novartis in an Extraordinary...
Sandoz gets exclusive rights to commercialize biosimilar SB17 ustekinumab in US, Canada, EEA, Switzerland and UK Ruchika Sharma11 Sept 2023 1:30 PM ISTThe reference medicine Stelara (ustekinumab) is a monoclonal antibody medication to interleukin (IL)-12/23 for the treatment of autoimmune disorders...
Sandoz concludes acquisition of antifungal agent Mycamine from Astellas Ruchika Sharma28 Aug 2023 5:40 PM ISTBasel: Sandoz has successfully completed the acquisition of worldwide brand rights for systemic antifungal agent Mycamine (micafungin sodium, Funguard...
